SCHEMBL28950185

SCHEMBL28950185

CCN(CCCN)CCCCO

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
HIF1A Q16665 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CHRM2 P08172 2/20 0.36
LMNA P02545 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TSHR P16473 1/20 0.35
KDM5A P29375 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
KCNH2 Q12809 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
CHRM1 P11229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28943310 0.93 HSD17B10 (0.38) HSD17B10CYP1A2CYP2C9HPGDMAPK1
Propanol SCHEMBL28950195 0.89 CHRM2 (0.39) HSD17B10CYP1A2CYP2C9HPGDMAPK1
SCHEMBL7178777 0.88 CYP1A2 (0.47) HSD17B10CYP1A2CYP2C9HPGDMAPK1
SCHEMBL465376 0.88 SMN1; SMN2 (0.45) HSD17B10CYP1A2CYP2C9HPGDMAPK1
SCHEMBL7185203 0.88 CHRM2 (0.43) CHRM2ALDH1A1MEN1KMT2ATSHR
SCHEMBL3092186 0.86 CYP1A2 (0.45) HSD17B10CYP1A2CYP2C9HPGDMAPK1
Monoethanolamine SCHEMBL8747970 0.86 ALDH1A1 (0.40) HSD17B10CYP1A2CYP2C9HPGDMAPK1
SCHEMBL15557660 0.85 CHRM2 (0.48) CHRM2ALDH1A1MEN1KMT2ATSHR
SCHEMBL465469 0.85 ALDH1A1 (0.48) HSD17B10CYP1A2CYP2C9HPGDMAPK1
SCHEMBL465358 0.85 ALDH1A1 (0.48) HSD17B10CYP1A2CYP2C9HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4387607-A1 NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS Tiba Biotech LLC (US) 2024-06-26 EP claimed
CN-117897152-A Nanoparticle compositions containing sugar-functionalized nucleic acid vectors 蒂巴生物技术有限公司 2024-04-16 CN claimed
WO-2023022926-A1 NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS TIBA BIOTECH LLC (US) 2023-02-23 WO claimed
CN-115702005-A Vectors for efficient nucleic acid delivery 蒂巴生物技术有限公司 2023-02-14 CN claimed
US-20260014077-A1 NOVEL METHODS TO ENHANCE GENE DELIVERY TIBA BIOTECH LLC (US) 2026-01-15 US disclosed
EP-4387607-A1 NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS Tiba Biotech LLC (US) 2024-06-26 EP disclosed
CN-117897152-A Nanoparticle compositions containing sugar-functionalized nucleic acid vectors 蒂巴生物技术有限公司 2024-04-16 CN disclosed
WO-2023022926-A1 NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS TIBA BIOTECH LLC (US) 2023-02-23 WO disclosed
CN-115702005-A Vectors for efficient nucleic acid delivery 蒂巴生物技术有限公司 2023-02-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260014077-A1 NOVEL METHODS TO ENHANCE GENE DELIVERY LDLR, NPC1L1, LIPG HSD17B10 1520/4885CYP1A2 2759/4885CYP2C9 1094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.